Search research articles
Contact Us
Filters
Showing results (111-120 of 136) with videos related to
Page
of 14
Sort By:
Blood
|
December 19, 2009
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
Lionel Adès, Agnes Guerci, Emmanuel Raffoux, et al.
Haematologica
|
June 1, 2023
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib
Ruben Mesa, Srdan Verstovsek, Uwe Platzbecker, et al.
Blood
|
January 17, 2013
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
Eric Jourdan, Nicolas Boissel, Sylvie Chevret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2017
Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study
Arnaud Pigneux, Marie C Béné, Philippe Guardiola, et al.
Blood Advances
|
February 11, 2021
Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort
Edmond Chiche, Ramy Rahmé, Sarah Bertoli, et al.
Blood
|
October 14, 2010
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine
Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, et al.
Blood Cancer Journal
|
April 21, 2022
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Keith W Pratz, Panayiotis Panayiotidis, Christian Recher, et al.
Blood
|
April 21, 2021
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study
Matthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2021
Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
Thomas Cluzeau, Marie Sebert, Ramy Rahmé, et al.
Nature Communications
|
May 26, 2021
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients
Florent Malard, Anne Vekhoff, Simona Lapusan, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 136) with videos related to
Sort By:
Page
of 14
Blood
|
December 19, 2009
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
Lionel Adès, Agnes Guerci, Emmanuel Raffoux, et al.
Haematologica
|
June 1, 2023
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib
Ruben Mesa, Srdan Verstovsek, Uwe Platzbecker, et al.
Blood
|
January 17, 2013
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
Eric Jourdan, Nicolas Boissel, Sylvie Chevret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2017
Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study
Arnaud Pigneux, Marie C Béné, Philippe Guardiola, et al.
Blood Advances
|
February 11, 2021
Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort
Edmond Chiche, Ramy Rahmé, Sarah Bertoli, et al.
Blood
|
October 14, 2010
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine
Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, et al.
Blood Cancer Journal
|
April 21, 2022
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Keith W Pratz, Panayiotis Panayiotidis, Christian Recher, et al.
Blood
|
April 21, 2021
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study
Matthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2021
Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
Thomas Cluzeau, Marie Sebert, Ramy Rahmé, et al.
Nature Communications
|
May 26, 2021
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients
Florent Malard, Anne Vekhoff, Simona Lapusan, et al.
Page
of 14